Chemistry:Anatumomab mafenatox
From HandWiki
Short description: Chemical compound
Monoclonal antibody | |
---|---|
Type | Fab fragment |
Source | Mouse |
Target | TAG-72 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
(verify) |
Anatumomab mafenatox is a mouse monoclonal antibody studied for the treatment non-small cell lung cancer,[1] which acts as a tumor-targeted superantigen.[2]
It is a fusion protein of a human tumor-associated 5T4 antigen monoclonal IgG1 Fab fragment with an enterotoxin ('mafenatox') of Staphylococcus aureus.[3]
Development was abandoned in 2005.[4]
References
- ↑ "Active Biotech". http://activebiotech.com/?oid=117&_locale=1.
- ↑ "Tumor-Targeted Superantigens". Fusion Protein Technologies for Biopharmaceuticals. 2013. pp. 365–381. doi:10.1002/9781118354599.ch24. ISBN 9781118354599.
- ↑ "Drug info". World Health Organization. http://whqlibdoc.who.int/druginfo/INN_1999_list41.pdf.
- ↑ "Anatumomab mafenatox". AdisInsight. Springer Nature Switzerland AG. http://adisinsight.springer.com/drugs/800013422.
Original source: https://en.wikipedia.org/wiki/Anatumomab mafenatox.
Read more |